Literature DB >> 2578067

Auto-injection of the corpus cavernosum with a vasoactive drug combination for vasculogenic impotence.

A W Zorgniotti, R S Lefleur.   

Abstract

Intracavernous injection of papaverine hydrochloride with phentolamine mesylate rapidly produces transitory penile tumescence, which can be followed by erection and coitus provided there is sexual stimulation. Coital penetration was possible in 59 of 62 patients with impotence of divers etiologies (vascular, diabetic, iatrogenic and Peyronie's disease) who underwent injection and were sent home to attempt coitus. One patient had a prolonged erection that was treated successfully with aspiration of a corpus. When coitus was successful the patient was offered training in self-injection. With self-injection 18 patients have had satisfactory coitus without a noteworthy complication; 5 for more than 12 months. The long-term effects of intracavernous injections remain unknown. Intracavernous injection of vasoactive substances (chemical prosthesis) may become a useful alternative treatment. Administration should be restricted to urologists able to manage the possible complication of priapism.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2578067     DOI: 10.1016/s0022-5347(17)48774-x

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  37 in total

1.  The assessment of pelvic circulation after internal iliac arterial reconstruction: a retrospective study of the treatment for vasculogenic impotence and hip claudication.

Authors:  T Iwai; S Sato; Y Muraoka; K Sakurazawa; H Kinoshita; Y Inoue; M Endo; T Yoshida
Journal:  Jpn J Surg       Date:  1989-09

2.  Sexual rehabilitation.

Authors:  R W Stevenson
Journal:  Can Fam Physician       Date:  1986-09       Impact factor: 3.275

3.  "Organic" erection dysfunction: diagnosis and treatment.

Authors:  R W Stevenson
Journal:  Can Fam Physician       Date:  1988-08       Impact factor: 3.275

4.  Comparison of Alprostadil (Caverject) and a combination of vasoactive drugs as local injections for the treatment of erectile dysfunction.

Authors:  H M Abdallah
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

5.  Treatment for impotence.

Authors:  R A Kaplan; J R White
Journal:  West J Med       Date:  1986-11

6.  Pharmacological priapism: comparison of trazodone- and papaverine-associated cases.

Authors:  E D Bardin; J N Krieger
Journal:  Int Urol Nephrol       Date:  1990       Impact factor: 2.370

7.  Toxicity assessment of papaverine hydrochloride and papaverine-derived metabolites in primary cultures of rat hepatocytes.

Authors:  J C Davila; C G Reddy; P J Davis; D Acosta
Journal:  In Vitro Cell Dev Biol       Date:  1990-05

Review 8.  Prevalence of post-prostatectomy erectile dysfunction and a review of the recommended therapeutic modalities.

Authors:  Thiago Fernandes Negris Lima; Joshua Bitran; Fabio Stefano Frech; Ranjith Ramasamy
Journal:  Int J Impot Res       Date:  2020-11-17       Impact factor: 2.896

9.  Correlation between intracavernous papaverine injection, Doppler analysis and cavernosography in impotent patients.

Authors:  Y S Sargin; H A Ozen; I Başar; A Ergen; I Celebi; D Erol; C Koçal; D Remzi
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

10.  Evaluation of the first 300 patients treated at an outpatient center for male sexual dysfunction.

Authors:  L R Ellis; R E Nellans; D J Kramer-Levien; G S Knoepfler; P Knoepfler
Journal:  West J Med       Date:  1987-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.